# Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-mh-27-205-single-source-accelerating-medicines-partnership/  
Official notice: https://www.grants.gov/search-results-detail/359699

> National Institutes of Health offered grants of up to $5.0 million to the applicants described in the notice. It expected to make one award worth $5.0 million in total. Applications closed on June 9, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-MH-27-205 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | June 9, 2026 |
| Award ceiling | $5.0 million |
| Award floor | not stated |
| Expected awards | 1 |
| Total funding | $5.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.242 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Eligible Organizations:Only the Brigham and Women's Hospital may apply for this single source NOFO.Only the following applicant is eligible to apply for this single source funding: Brigham and Women"s Hospital. Please refer to Section I. Notice of Funding Opportunity Information for more details. Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

## What the grant funds

NIMH is announcing its intent to issue a single source cooperative agreement award to Brigham and Women"s Hospital to support continuation of the AMP® SCZ Data Processing, Analysis, and Coordination Center (DPACC). This allows DPACC to complete the processing and analysis of longitudinal multi-modal biomarker and clinical outcome data collected across 24 months. This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

## Questions people ask

### Is RFA-MH-27-205 still open?

No. It closed on June 9, 2026.

### Who can apply for Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Single Source: Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Data Processing, Analysis, and Coordination Center (DPACC) (U24 Clinical Trial Not Allowed)?

Closed June 9, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $5.0 million each. About $5.0 million in total for one award.

### Who has won Mental Health Research Grants grants before?

The largest recipients over five fiscal years were Yale Univ, University of Pittsburgh - of the Commonwealth System of Higher Education, University of California, Los Angeles. The program made 6,785 awards worth $8.8 billion in that time.